Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Sepsis Response Team in the Emergency Department

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03789838
Recruitment Status : Completed
First Posted : December 31, 2018
Last Update Posted : December 31, 2018
Sponsor:
Information provided by (Responsible Party):
Aleksander Rygh Holten, Oslo University Hospital

Brief Summary:
Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour?

Condition or disease Intervention/treatment
Sepsis Other: Sepsis rapid response team

Detailed Description:
Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour? The time from the patients arrive at the emergency department to an adequate antibiotic is given, before and after introduction of a sepsis response team, was registered.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 245 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Prospective Cohort Study Examining the Effect of a Sepsis Rapid Response Team in the Emergency Department
Actual Study Start Date : May 15, 2017
Actual Primary Completion Date : May 15, 2018
Actual Study Completion Date : May 15, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sepsis

Group/Cohort Intervention/treatment
Before of sepsis rapid response team
Time from arrival at the Emergency Department to antibiotic is administered, before introduction of sepsis response team in the Emergency Department.
Sepsis rapid response team
Time from arrival at the Emergency Department to antibiotic is administered, with sepsis response team in the Emergency Department.
Other: Sepsis rapid response team
Patients with suspected sepsis is managed by a sepsis rapid response team in a structured manner.




Primary Outcome Measures :
  1. Time from arrival the emergency department to antibiotic is given. [ Time Frame: 6 months ]
    Time from arrival the emergency department to antibiotic is given.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patients with suspected sepsis in emergency department
Criteria

Inclusion Criteria:

  • Patients with suspected sepsis

Exclusion Criteria:

  • Patients who was consider not to need antibiotics

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789838


Locations
Layout table for location information
Norway
Oslo University Hospital
Oslo, Norway, 0424
Sponsors and Collaborators
Oslo University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Aleksander Holten, Phd, MD Oslo University Hospital

Additional Information:

Layout table for additonal information
Responsible Party: Aleksander Rygh Holten, Consultant Physician, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03789838     History of Changes
Other Study ID Numbers: Ulleval sepsis-01
First Posted: December 31, 2018    Key Record Dates
Last Update Posted: December 31, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Sepsis
Toxemia
Emergencies
Disease Attributes
Pathologic Processes
Infection
Systemic Inflammatory Response Syndrome
Inflammation